Omicron remains a wild card in the equation with the full impact of the new coronavirus variant as yet unclear, analysts said
Cabinet clears Rs 76,000-cr incentive scheme for semiconductors; Paytm nears record low, down 13% as anchor investors' lock-in period ends
The broader markets also weakened towards the end of the trading session; Sun Pharma, however, gained nearly 3 per cent.
The dollar index which measures the greenback against six major peers was at 96.557, having gained 0.5% so far this week in choppy trading
Asian markets stood still on Wednesday as the world waited to hear from US Federal Reserve on when it would stop buying assets and start raising interest rates
Why's India short on investment advisors? What is the investment strategy of ICICI Venture's Puneet Nanda? Will US Fed increase pace of tapering? What is RT-PCR & Rapid Antigen Test? All answers here
NBFCs to come under the ambit of PCA framework from Oct 2022; Anand Rathi Wealth debuts at 9% premium; WPI-based inflation hits 12-year high of 14.2% in Nov
The dollar traded near a one-week high versus a basket of major rivals on Tuesday, supported by expectations of a hawkish Federal Reserve meeting this week
Asian stocks and oil prices slipped on Tuesday as the spread of the Omicron coronavirus variant rattled investors who were already on edge ahead of a slew of central bank decisions this week
The U.S. Federal Reserve is expected to signal a faster wind-down of asset purchases, which could move it one step closer to raising interest rates
The US Federal Reserve is expected to announce this week that the central bank will accelerate the pace of tapering asset purchases and prepare for raising interest rates in 2022
Apple closes in on becoming first $3 trillion company; Pfizer to buy Arena Pharma, shares of both companies rise
Mobile device maker Realme has overtaken South Korean giant Samsung to grab the second spot in the branded smartphone market. More on that in today's top headlines
In contrast to the US, India is in the early stages of its inflation journey
Uncertainties remain over Omicron even as optimism it may cause milder illness has helped boost markets
The US' annual inflation will remain above the Federal Reserve's target of 2 per cent over the next three years, according to a survey
LONDON/SYDNEY (Reuters) - European shares opened firmer on Friday, shrugging off weakness in Asia as markets appeared to be slowly accepting the possibility of more COVID-linked activity curbs and an accelerated pace of stimulus tapering by the U.S. Federal Reserve.
In the past 10 years (since 2011), markets have delivered a positive return in 5 out of 10 occasions with gains for the S&P BSE Sensex ranging between 0.4 per cent to 8.2 per cent, data shows
Gold prices eased as investors gauged the US Federal Reserve's response to inflationary risks and economic recovery concerns over Omicron
Foreign-exchange market volatility hovered near a nine-month peak as traders weighed the risks posed by a more hawkish Federal Reserve